Soluble guanylyl cyclase expression and signaling in different types of liver fibrosisKsenia Brusilovskaya, Thomas Reiberger, Philipp Königshofer et al.|Journal of Hepatology|2022Cited by 0
Hemodynamic, molecular, and histological characterization of a toxic liver fibrosis regression modelPhilipp Königshofer, Thomas Reiberger, Ksenia Brusilovskaya et al.|Journal of Hepatology|2022Cited by 0
THU-540 Characterization of in vivo mouse models of regressive fibrosis and resolving portal hypertensionKatharina Bonitz, Thomas Reiberger, Philipp Königshofer et al.|Journal of Hepatology|2024Cited by 0
WED-122-YI The soluble guanylate cyclase pathway is dysregulated in rodent models of cirrhosis and portal hypertensionThomas Sorz‐Nechay, Thomas Reiberger, Ksenia Brusilovskaya et al.|Journal of Hepatology|2024Cited by 0
WED-125 Differential regulation of soluble guanylate cyclase signaling during liver fibrosis regressionThomas Sorz‐Nechay, Thomas Reiberger, Ksenia Brusilovskaya et al.|Journal of Hepatology|2024Cited by 0